Filing Details

Accession Number:
0000899243-18-009260
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-03 17:07:57
Reporting Period:
2018-04-03
Accepted Time:
2018-04-03 17:07:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1622229 Unum Therapeutics Inc. UMRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451612 Bruce Booth C/o Unum Therapeutics Inc.
200 Cambridge Park Drive, Suite 3100
Cambridge MA 02140
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-03 3,184,446 $0.00 3,184,446 No 4 C Indirect See Footnote
Common Stock Acquisiton 2018-04-03 83,037 $0.00 3,267,483 No 4 C Indirect See Footnote
Common Stock Acquisiton 2018-04-03 94,052 $12.00 3,361,535 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2018-04-03 3,184,446 $0.00 3,184,446 $0.00
Common Stock Series B Preferred Stock Disposition 2018-04-03 83,037 $0.00 83,037 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share automatically converted into Common Stock, for no additional consideration, on a 1.5701314513884-for-1 basis at the closing of the Issuer's initial public offering. The shares had no expiration date.
  2. The shares are held directly by Atlas Venture Fund IX, L.P. ("Atlas Venture Fund IX"). The general partner of Atlas Venture Fund IX is Atlas Venture Associates IX, L.P. ("AVA IX LP"). Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. Dr. Booth is a member of AVA IX LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund IX, except to the extent of his pecuniary interest therein, if any.